Moreover, vitamin D3, the parathyroid hormone analog Teriparatide, and RANKL inhibitors (the antibody Denosumab) are among the medications that counteract osteoporosis pathological mechanisms [150]. Here, TNFSF11 is linked to osteoporosis.